Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.43 USD | -6.54% | -25.91% | -59.17% |
May. 14 | Transcript : TRACON Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Earnings Flash (TCON) TRACON PHARMACEUTICALS Posts Q1 Revenue $100,000 | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 3.25M |
---|---|---|---|---|---|
Net income 2024 * | -20M | Net income 2025 * | -21M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.44
x | P/E ratio 2025 * |
-0.39
x | Employees | 17 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.8% |
Latest transcript on TRACON Pharmaceuticals, Inc.
1 day | -6.54% | ||
1 week | -25.91% | ||
Current month | -17.34% | ||
1 month | -32.23% | ||
3 months | -61.72% | ||
6 months | -57.42% | ||
Current year | -59.17% |
Managers | Title | Age | Since |
---|---|---|---|
Charles Theuer
CEO | Chief Executive Officer | 60 | 06-06-30 |
Scott Brown
DFI | Director of Finance/CFO | 43 | 15-07-31 |
James L. Freddo
CTO | Chief Tech/Sci/R&D Officer | 69 | 20-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Martin Mattingly
BRD | Director/Board Member | 66 | 14-12-25 |
Director/Board Member | 54 | 20-03-18 | |
Stephen Worland
BRD | Director/Board Member | 66 | 15-02-24 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 1.43 | -6.54% | 119,558 |
24-05-16 | 1.53 | -5.56% | 108,043 |
24-05-15 | 1.62 | -17.77% | 206,969 |
24-05-14 | 1.97 | -2.48% | 169,230 |
24-05-13 | 2.02 | +4.66% | 150,481 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-59.17% | 3.25M | |
-2.32% | 90.45B | |
+3.68% | 41.45B | |
-10.90% | 33.57B | |
+58.05% | 25.73B | |
-19.56% | 14.73B | |
-9.06% | 12.82B | |
-11.34% | 11.7B | |
-43.53% | 11.44B | |
+3.75% | 8.79B |
- Stock Market
- Equities
- TCON Stock